<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>)-specific antibody (anti-GP70), previously described, was used to analyse 22 different <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-cell lines </plain></SENT>
<SENT sid="1" pm="."><plain>The results indicated specificity of antibodies to lines that contain both surface membrane Ig (SmIg) and cytoplasmic Ig (CyIg) </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-cell lines derived from more immature B cells that do not have SmIg but rather have only CyIg were negative </plain></SENT>
<SENT sid="3" pm="."><plain>A comparative study with antibody to <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">common ALL</z:e> antigen (CALLA) and to another <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-specific antigen (BLA) revealed coexpression of GP70 with those two antigens, but no identity between them </plain></SENT>
</text></document>